Daniel R. Boster
Impact in
- Endocrinology top 2%
- Escherichia coli research studies
- Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology
- Clostridium difficile and Clostridium perfringens research
Papers in
-
- Escherichia coli research studies 4
- Enterobacteriaceae and Cronobacter Research 1
- Infections and bacterial resistance 1
-
- Viral gastroenteritis research and epidemiology 2
- Clostridium difficile and Clostridium perfringens research 1
- Co-authors
- Phillip I. Tarr (8 shared papers)Jennifer R. Stapp (4 shared papers)Xuan Qin (4 shared papers)David L. Swerdlow (3 shared papers)Carla R. Clausen (3 shared papers)Eileen J. Klein (2 shared papers)Joy G. Wells (2 shared papers)Christopher R. Braden (3 shared papers)
- Journals
- The Journal of Infectious Diseases (2 papers)New England Journal of Medicine (1 paper)Clinical Infectious Diseases (1 paper)Journal of Clinical Microbiology (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
Daniel R. Boster
7 papers receiving 483 citations
Peers
Comparison fields: 5 of 70
- Endocrinology 222
- Infectious Diseases 290
- Nephrology 31
- Immunology 93
- Applied Microbiology and Biotechnology 6
Countries citing papers authored by Daniel R. Boster
This map shows the geographic impact of Daniel R. Boster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel R. Boster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel R. Boster more than expected).
Fields of papers citing papers by Daniel R. Boster
This network shows the impact of papers produced by Daniel R. Boster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel R. Boster. The network helps show where Daniel R. Boster may publish in the future.
Co-authors
The 19 scholars most cited alongside Daniel R. Boster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 150 | |
| 2 | 2002 | 142 | |
| 3 | 2002 | 111 | |
| 4 | 2005 | 55 | |
| 5 | 2006 | 54 | |
| 6 | 2002 | 22 | |
| 7 | 2002 | 11 | |
| 8 | 2002 | 1 |
About Daniel R. Boster
Daniel R. Boster is a scholar working on Endocrinology, Infectious Diseases, Immunology, Molecular Medicine and Organic Chemistry, having authored 8 papers that have together received 546 indexed citations. Recurring topics across this work include Escherichia coli research studies (4 papers), Viral gastroenteritis research and epidemiology (2 papers), Complement system in diseases (2 papers), Clostridium difficile and Clostridium perfringens research (1 paper), Antibiotic Resistance in Bacteria (1 paper), Enterobacteriaceae and Cronobacter Research (1 paper) and Infections and bacterial resistance (1 paper). The work is most often cited by research in Endocrinology (222 citations), Infectious Diseases (290 citations), Nephrology (31 citations), Immunology (93 citations) and Applied Microbiology and Biotechnology (6 citations). Daniel R. Boster has collaborated with scholars based in United States and Japan. Frequent co-authors include Phillip I. Tarr, Jennifer R. Stapp, Xuan Qin, David L. Swerdlow, Carla R. Clausen, Eileen J. Klein, Joy G. Wells, Christopher R. Braden, Marcia A. Ciol and Srdjan Jelačić. Their work appears in journals such as The Journal of Infectious Diseases, New England Journal of Medicine, Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.